Beckman Coulter Scalable Immunoassay Analyzers
Designed for the needs of the Mid- to High-Volume Immunoassay Laboratory
The UniCel DxI Access Immunoassay Analyzers combine high-throughput, reduced maintenance and intuitive controls to improve laboratory efficiency, simplify processes and save time.
Discover the newDxI 9000
Immunoassay Analyzer which
creates time for you to focus on what matters most with Zero Daily Maintenance.
Explore below!
DxC 500i
Automate Your Chemistry and Immunoassay Testing
Watch how the DxC 500i Clinical Analyzer automates chemistry and immunoassay testing to move through your sample queue faster and smarter than two stand-alone analyzers.
ACCESS 2
LOW VOLUME
Reliability matters
This benchtop immunoassay analyzer fits labs with space constraints and delivers fast, reliable results.
ANNUAL TEST VOLUME
< 40.000
THROUGHPUT > 100 tests/hours
DxI 600
MID VOLUME
Symplicity results.
This
immunoassay analyzer gives technologists the benefit of ease of use without
sacrificing throughput.
ANNUAL TEST VOLUME
< 40.000 to 80.000
THROUGHPUT > 200 tests/hours
DxI 800
HIGH VOLUME
Scalability matters.
This immunoassay system supports the expanding needs of your growing laboratory.
ANNUAL TEST VOLUME
< 80.000
THROUGHPUT > 400 tests/hours
DxI 9000
MID TO HIGH VOLUME
Your time matters
Zero Daily Maintenance to amplify productivity.
Simple solve onboard guide.
ANNUAL TEST VOLUME
< 80.000
THROUGHPUT
> 450 tests/hours
Expect More From Your Menu
Improve patient care with our broad menu of high-quality, reliable assays. Explore some of our many solutions for today’s busy labs.
NEW High-quality immunossays blood-based tests enable laboratory to early detect Alzheimer diseases in a less invasive way.
New emerging blood tests aim to detect Alzheimer in a less invasive and more accessible way. Labs Could Soon Play Leading Roles in Alzheimer’s Disease Testing. Rather than relying on invasive and often hard-to-access methods like CSF testing and PET scans, the future of Alzheimer’s testing could very well center around the lab.Several new and emerging blood tests aim to detect Alzheimer’s biomarkers in a less invasive and more accessible way.
Syphilis TP Latex Immunoassay test available on DxI 9000
Early detection through testing can help prevent the further transmission of syphilis and allow for timely treatment, reducing the risk of severe health complications of tertiary syphilis like organ damage and death. Syphilis is globally prevalent, with the World Health Organization estimating that 8 million adults aged 15-49 contracted the disease in 2022. Although it can be effectively managed with antibiotics, untreated cases may result in serious health complications. This new Beckman Coulter’s Access Syphilis assay is intended to be used as an aid in the diagnosis of syphilis and as a screening test for blood donors. With > 99% clinical sensitivity and multiple validated sample types, you can be confident in patient results.
Prostate Cancer Detection PSA Testing
Early detection can lead to better outcomes. However, for some men, one of the most common detection methods — prostate biopsy — may offer more risk than benefit. How the Prostate Health Index (phi) helps answer To Biopsy or Not To Biopsy” - What is phi ? The benefit of phi
Explore Expanding Cardiac Menu With NT-proBNP
Natriuretic peptides reflect cardiac status and effects of therapy
Access BNP and NT-proBNP immunoassays are used to aid in the diagnosis of heart failure and left ventricular dysfunction.1
B‐type natriuretic peptide (BNP) is a cardiac hormone originating in the heart.2 In patients with heart failure, BNP and NT-proBNP levels are elevated.3 They can be assessed as important measures of cardiac function and diagnosis of heart failure.4